Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 7;124(6):907-12.
doi: 10.1182/blood-2014-03-565051. Epub 2014 Jun 23.

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

Wilson I Gonsalves  1 , S Vincent Rajkumar  2 , Ronald S Go  1 , Angela Dispenzieri  1 , Vinay Gupta  1 , Preet P Singh  1 , Francis K Buadi  1 , Martha Q Lacy  1 , Prashant Kapoor  1 , David Dingli  1 , John A Lust  2 , Steven R Zeldenrust  1 , Suzanne R Hayman  1 , Robert A Kyle  1 , Morie A Gertz  1 , Shaji K Kumar  1
Affiliations

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

Wilson I Gonsalves et al. Blood. .

Abstract

Primary plasma cell leukemia (pPCL) is a rare malignancy with an aggressive course and poor outcome. There has been significant improvement in the survival of multiple myeloma patients over the past decade as a result of incorporating autologous stem cell transplantation (ASCT) and novel agents into treatment regimens. However, it is unknown whether these therapies have had a similar impact on the survival of patients with pPCL. We conducted an analysis of the Surveillance, Epidemiology, and End Results database to evaluate the trends in survival of 445 patients with pPCL between 1973 and 2009. The widespread availability of ASCT and use of novel agents in the upfront setting of multiple myeloma and pPCL began after 1995 and 2006, respectively. The median overall survival based on periods of diagnosis were 5, 6, 4, and 12 months for those diagnosed during 1973-1995, 1996-2000, 2001-2005, and 2006-2009, respectively (P = .001). Thus, the current study confirms the recent survival improvement in pPCL within a large US population that may be associated with the use of better therapeutic strategies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier Curve for OS in pPCL patients based on period of diagnosis.
Figure 2
Figure 2
Kaplan-Meier curves. (A) Kaplan-Meier curve for OS in pPCL patients based on period of diagnosis in patients younger than 65 years of age. (B) Kaplan-Meier curve for OS in pPCL patients based on period of diagnosis in patients 65 years of age or older.
See this image and copyright information in PMC

References

    1. Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med. 1987;83(6):1062–1068. - PubMed
    1. IMWG. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749–757. - PubMed
    1. Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974;133(5):813–818. - PubMed
    1. Blade J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 1999;13(6):1259–1272. - PubMed
    1. Tiedemann RE, Gonzalez-Paz N, Kyle RA, et al. Genetic aberrations and survival in plasma cell leukemia. Leukemia. 2008;22(5):1044–1052. - PMC - PubMed

Publication types

MeSH terms